EXC vs IOVA · P/E 17, rev $24.26B vs rev $170.7M
Exelon Corporation (EXC) versus Iovance Biotherapeutics Inc (IOVA) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. IOVA currently screens at market cap $1.89B.
Not investment advice. Open the EXC and IOVA stock pages for the full models.
Not investment advice.